Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non–small cell lung cancer in the randomized phase III IMpower010 trial - The Journal of Thoracic and Cardiovascular Surgery
Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non–small cell lung cancer in the randomized phase III IMpower010 trial - The Journal of Thoracic and Cardiovascular Surgery
Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non–small cell lung cancer in the randomized phase III IMpower010 trial - The Journal of Thoracic and Cardiovascular Surgery,肝臓の問題 | オステオパシー 東京渋谷 OMT-LAB Osteopathy Shibuya Tokyo,Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide - Lung Cancer,Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition: Cell Reports,ASCO GU 2020: New Standards in First-Line Therapy for Advanced Disease